University of Sharjah Center for Diabetes | United Arab Emirates
Prof. Salah Abusnana is an accomplished clinician, academic leader, and researcher in diabetes, endocrinology, and internal medicine, with over three decades of clinical practice and significant contributions to medical education and healthcare management. He earned his MSc in Neuroendocrinology, PhD from Imperial College London, and advanced postgraduate qualifications including MRCP and CCST in Endocrinology, Diabetes, and Internal Medicine. His extensive career spans senior clinical positions across major London university hospitals and leading roles in the UAE as Senior Consultant, Head of Diabetes and Endocrine Department, Professor, Deputy Chair of Clinical Sciences, Medical Director at RCDR, and Chief Medical Officer at SKMCA. His research focuses on neuroendocrinology, obesity, appetite regulation, diabetes care, and metabolic disorders, leading to numerous peer-reviewed publications and the establishment of fully structured research units and national-level programs. He has supervised MSc and PhD scholars and played key roles in developing diabetes guidelines, PHC training programs, and national research initiatives. A recognized leader, he contributed significantly to hospital commissioning, curriculum development, and clinical service expansion. Widely respected for his work, he continues to advance diabetes research, education, and clinical excellence through leadership roles and collaborative initiatives.
Featured Publications
Ramakrishnan, R.K., Srivastava, A., Rajan, R., Abusnana, S., & Mussa, B.M. (2024). “Investigating the role of an immediate early gene FOS as a potential regulator of autophagic response to hypoglycemia in embryonic hypothalamic neurons.” Clinical and Translational Science.
Hassanein, M., Sabbour, H., Al Awadi, F., Abusnana, S., Afandi, B., Al Kaabi, J., Bashier, A., Cosentino, F., El Tamimi, H., Farghali, M., et al. (2023). “Cardiometabolic Guidelines: Cardiovascular Risk Assessment and Management in Patients with Dysglycemia.” Dubai Diabetes and Endocrinology Journal.
Alnimer, A., Bhamidimarri, P.M., Talaat, I.M., Alkhayaal, N., Eltayeb, A., Ali, N., Abusnana, S., Hamoudi, R., & Bendardaf, R. (2023). “Association Between Expression of Vitamin D Receptor and Insulin-Like Growth Factor 1 Receptor Among Breast Cancer Patients.” World Journal of Oncology.
Zakaria, H., Abusanana, S., Mussa, B.M., Al Dhaheri, A.S., Stojanovska, L., Mohamad, M.N., Saleh, S.T., Ali, H.I., & Ismail, L.C. (2023). “The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus.” Medicina.
Mussa, B.M., Srivastava, A., Al-Habshi, A., Mohammed, A.K., Halwani, R., & Abusnana, S. (2021). “Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.
Bendardaf, R., Saheb Sharif-Askari, F., Saheb Sharif-Askari, N., Guraya, S.Y., AlMadhi, S.A., & Abusnana, S. (2020). “Incidence and Clinicopathological Features of Breast Cancer in the Northern Emirates: Experience from Sharjah Breast Care Center.” International Journal of Women’s Health.
Saheb Sharif-Askari, F., Saheb Sharif-Askari, N., Halwani, R., Abusnana, S., Hamoudi, R., & Sulaiman, N. (2020). “Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.
Mussa, B.M., Schauman, M., Ramalingam, V., Skaria, S., & Abusnana, S. (2019). “Personalized intervention to improve stress and sleep patterns for glycemic control and weight management in obese Emirati patients with type 2 diabetes: a randomized controlled clinical trial.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.